On October 20, 2026 Amgen (NASDAQ:AMGN) reported it will host a webcast call for the investment community in conjunction with the European Society of Medical Oncology (ESMO) (Free ESMO Whitepaper) Congress (ESMO) (Free ESMO Whitepaper) 2026 on Saturday, October 24, 2026 at 11:30 a.m. PT. Murdo Gordon, executive vice president of Global Markets and Policy at Amgen, and Jean-Charles Soria, senior vice president of oncology within Global Development at Amgen, as well as other members of Amgen’s management team, will discuss Amgen’s oncology portfolio and selected data being presented at ESMO (Free ESMO Whitepaper) 2026. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webcast, as with other selected presentations regarding developments in Amgen’s business given by management at certain investor and medical conferences, can be found on Amgen’s website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen’s Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 30 days after the event.

(Press release, Amgen, OCT 20, 2026, View Source [SID1234673616])